“Komen supports research on the isolation, derivation, production, and testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of or treatments for breast cancer, but are derived without creating a human embryo or destroying a human embryo,” Komen says. “A priority in our research funding is to quickly find and deliver effective treatments, especially for the most lethal forms of breast cancer, while seeking effective preventive strategies, enhanced screening methodologies, and solutions to disparities in breast cancer outcomes for diverse women.”
Meanwhile, as LifeNews reported, new Komen Vice President for public policy Karen Handel, a pro-life advocate for Georgia, also opposes embryonic stem cell research. She has been credited with being instrumental in helping stop the Planned Parenthood funding.
“I oppose embryonic stem cell research, which creates life solely for the purpose of destroying it. I do, however, strongly support adult stem cell research, which has produced numerous scientific achievements without terminating innocent lives in the process,” Handel said in 2010 as a candidate for the U.S. Senate.
(link to full article)